Core Viewpoint - The stock price of Meiansen has experienced fluctuations, with a year-to-date decline of 8.45% and a recent recovery over the last five trading days, indicating potential volatility in investor sentiment [2]. Group 1: Stock Performance - As of November 11, Meiansen's stock price decreased by 2.04%, trading at 13.43 CNY per share, with a total market capitalization of 4.137 billion CNY [1]. - Year-to-date, Meiansen's stock has dropped by 8.45%, but it has seen a 4.60% increase over the last five trading days and a 9.90% increase over the last 20 days [2]. Group 2: Financial Performance - For the period from January to September 2025, Meiansen reported a revenue of 317 million CNY, reflecting a year-on-year decrease of 9.80%, while the net profit attributable to shareholders was approximately 39.59 million CNY, down 14.49% year-on-year [2]. - The company has distributed a total of 1.05 billion CNY in dividends since its A-share listing, with 21.62 million CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders in Meiansen was 24,300, a decrease of 1.89% from the previous period, with an average of 11,178 circulating shares per shareholder, an increase of 9.31% [2]. - Notably, the top ten circulating shareholders saw a change, with Huaxia Stable Growth Mixed Fund exiting the list [3].

Core Viewpoint - Xiwang Food's stock price has shown fluctuations with a recent increase, but the company has faced a decline in revenue and net profit year-on-year, indicating potential challenges ahead [1][2]. Financial Performance - As of September 30, Xiwang Food reported a revenue of 3.507 billion yuan, a year-on-year decrease of 8.04% [2]. - The net profit attributable to shareholders was 2.2219 million yuan, reflecting a significant year-on-year decline of 96.45% [2]. - The company's stock price has decreased by 3.89% year-to-date, but it has increased by 4.53% in the last five trading days and 11.97% over the last 20 days [1]. Shareholder Information - The number of shareholders as of September 30 was 46,900, a decrease of 19.99% from the previous period [2]. - The average number of circulating shares per shareholder increased by 24.99% to 22,997 shares [2]. Dividend Information - Xiwang Food has cumulatively distributed 370 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Company Overview - Xiwang Food, established on January 31, 2011, and listed on November 26, 1996, is located in Zouping City, Shandong Province [1]. - The company's main business includes the production and sale of corn oil, as well as the research, production, and sale of sports nutrition and weight management products [1]. - The revenue composition is as follows: nutritional supplements 44.83%, plant oil 44.47%, and others 10.70% [1]. Industry Classification - Xiwang Food is classified under the Shenwan industry as food and beverage - food processing - health products [1]. - The company is associated with several concept sectors, including small-cap, low-price, supply and marketing cooperatives, NMN concept, and margin trading [1].

Core Viewpoint - Dezheng Health's stock price has experienced fluctuations, with a year-to-date increase of 39.30%, but a recent decline in trading performance [1][2]. Group 1: Stock Performance - On November 11, Dezheng Health's stock fell by 2.02%, trading at 4.36 CNY per share, with a total market capitalization of 9.143 billion CNY [1]. - The stock has seen a net outflow of 21.3992 million CNY in principal funds, with significant selling pressure observed [1]. - Year-to-date, the stock has risen by 39.30%, but has seen a slight decline of 1.13% over the last five trading days [1]. Group 2: Financial Performance - For the period from January to September 2025, Dezheng Health reported a revenue of 278 million CNY, a year-on-year decrease of 21.71%, and a net profit attributable to shareholders of -61.0254 million CNY, a significant decline of 854.37% [2]. - The company has not distributed any dividends in the last three years, with a total payout of 470 million CNY since its A-share listing [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders decreased to 57,600, with an average of 36,404 circulating shares per person, reflecting a slight decline [2]. - The Hong Kong Central Clearing Limited has exited the list of the top ten circulating shareholders [3].

Core Viewpoint - Nanjing South Medical Co., Ltd. (南卫股份) experienced a stock price decline of 2.11% on November 11, with a current price of 6.95 CNY per share, reflecting a total market capitalization of 2.009 billion CNY [1] Group 1: Stock Performance - The stock has increased by 59.77% year-to-date, with a 1.61% rise over the last five trading days and a 13.01% increase over the last 20 days, while it has decreased by 0.86% over the last 60 days [1] - As of September 30, the number of shareholders decreased by 16.70% to 12,000, while the average circulating shares per person increased by 20.05% to 23,992 shares [2] Group 2: Financial Performance - For the period from January to September 2025, the company reported a revenue of 447 million CNY, a year-on-year decrease of 1.70%, and a net profit attributable to shareholders of -24.93 million CNY, representing a significant year-on-year decline of 87.25% [2] - Cumulatively, the company has distributed 77.52 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3] Group 3: Business Overview - Nanjing South Medical Co., Ltd. specializes in the research, production, and sales of transdermal products, medical adhesive tapes, bandages, sports protection products, first aid kits, and nursing products [1] - The main revenue sources are as follows: adhesive bandages (39.59%), protective products (28.11%), adhesive tapes and bandages (22.54%), dressings (5.01%), first aid kits (2.63%), others (1.71%), and topical agents (0.40%) [1]

资料显示，华夏幸福基业股份有限公司位于北京市朝阳区东三环北路霞光里18号佳程广场A座23层，成 立日期1993年5月28日，上市日期2003年12月30日，公司主营业务涉及对房地产、工业园区及基础设施 建设投资;房地产中介服务;提供施工设备服务;企业管理咨询;生物医药研发,科技技术推广、服务。主营 业务收入构成为：房地产开发29.37%，物业管理服务22.96%，产业招租服务14.61%，其他(补 充)11.06%，产业园运营6.89%，土地整理6.83%，基础设施建设5.38%，酒店及学校运营1.69%，综合服 务1.22%。 华夏幸福所属申万行业为：房地产-房地产开发-产业地产。所属概念板块包括：小盘、体育产业、京津 冀、低价、通用航空等。 截至9月30日，华夏幸福股东户数16.70万，较上期减少6.22%；人均流通股23316股，较上期增加 6.63%。2025年1月-9月，华夏幸福实现营业收入38.82亿元，同比减少72.09%；归母净利润-98.29亿元， 同比减少338.67%。 11月11日，华夏幸福盘中上涨2.24%，截至13:54，报2.28元/股，成交2.82亿元，换手率3.23%，总市值 ...

Core Points - The stock price of Baihehua increased by 2.23% on November 11, reaching 16.94 CNY per share, with a trading volume of 282 million CNY and a turnover rate of 4.15% [1] - Baihehua's stock has risen 85.14% year-to-date, but has seen a decline of 12.64% over the last five trading days [2] - The company has been listed on the Longhu list five times this year, with the most recent occurrence on November 5, where it recorded a net buy of -1.7464 million CNY [2] Company Overview - Baihehua Group Co., Ltd. is located in Hangzhou, Zhejiang Province, and was established on August 11, 1995, with its listing date on December 20, 2016 [2] - The company's main business involves the research, production, sales, and service of organic pigments, intermediates, and pearlescent pigments, with revenue composition being 89.33% from pigments, 9.60% from intermediates, and 1.06% from others [2] - Baihehua belongs to the Shenwan industry classification of basic chemicals - chemical products - coatings and inks, and is associated with concepts such as small-cap, lithium batteries, dyes and coatings, share buybacks, and sodium batteries [2] Financial Performance - As of September 30, 2025, Baihehua reported a revenue of 1.638 billion CNY, a year-on-year decrease of 8.58%, and a net profit attributable to shareholders of 135 million CNY, down 5.84% year-on-year [2] - The company has distributed a total of 563 million CNY in dividends since its A-share listing, with 191 million CNY distributed over the last three years [3] - As of September 30, 2025, the number of shareholders decreased by 24.69% to 18,800, while the average circulating shares per person increased by 32.78% to 21,813 shares [2]

Core Viewpoint - The stock price of Guangdong Yuehai Feed has shown fluctuations, with a year-to-date decline of 11.68% but a recent recovery in the last five trading days, indicating potential market interest and volatility [2]. Group 1: Stock Performance - As of November 11, the stock price increased by 2.01% to 7.62 CNY per share, with a trading volume of 31.95 million CNY and a market capitalization of 5.334 billion CNY [1]. - The stock has experienced a 4.67% increase over the last five trading days and a 7.02% increase over the last 20 trading days, while it has decreased by 2.53% over the last 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, the company reported a revenue of 4.997 billion CNY, representing a year-on-year growth of 12.18%, and a net profit attributable to shareholders of 26.198 million CNY, which is a significant increase of 138.86% [2]. - The company has distributed a total of 185 million CNY in dividends since its A-share listing, with 147 million CNY distributed over the past three years [3]. Group 3: Company Overview - Guangdong Yuehai Feed, established on January 13, 1994, and listed on February 16, 2022, specializes in the research, production, and sales of aquatic feed, primarily focusing on shrimp and marine fish feed [2]. - The company's revenue composition includes 90.25% from feed sales, 8.23% from other sources, and 1.52% from animal health products [2]. - The company is categorized under the agricultural, forestry, animal husbandry, and fishery industry, specifically in the feed and aquatic feed sector [2].

Core Viewpoint - Yunnan Chengtou's stock price has shown a positive trend with a year-to-date increase of 4.87%, reflecting a growing interest in the company's performance despite recent financial challenges [1][2]. Financial Performance - For the period from January to September 2025, Yunnan Chengtou reported operating revenue of 1.336 billion yuan, a year-on-year decrease of 2.97% [2]. - The company recorded a net profit attributable to shareholders of -35.22 million yuan, representing a significant year-on-year decline of 296.01% [2]. Stock Market Activity - On November 11, Yunnan Chengtou's stock rose by 2.19%, reaching 2.80 yuan per share, with a trading volume of 107 million yuan and a turnover rate of 2.41% [1]. - The company has appeared on the "Dragon and Tiger List" three times this year, with the most recent instance on September 24, where it saw a net purchase of 2.35 million yuan [1]. Shareholder Information - As of October 31, 2025, Yunnan Chengtou had 54,200 shareholders, an increase of 3.25% from the previous period [2]. - The average circulating shares per person decreased by 3.15% to 29,629 shares [2]. Dividend History - Since its A-share listing, Yunnan Chengtou has distributed a total of 707 million yuan in dividends, with no dividends paid in the last three years [3]. Institutional Holdings - As of September 30, 2025, the sixth largest circulating shareholder is the Southern CSI Real Estate ETF, holding 12.1863 million shares, a decrease of 82,200 shares from the previous period [3].

Core Viewpoint - Kanghui Co., Ltd. has shown a significant stock price increase of 64.07% year-to-date, indicating strong market interest and potential growth in the pharmaceutical sector [2]. Financial Performance - As of September 30, Kanghui Co., Ltd. reported a revenue of 356 million yuan, a year-on-year decrease of 11.97%, and a net profit attributable to shareholders of -133 million yuan, reflecting a substantial decline of 246.07% [2]. - The company has cumulatively distributed 54.23 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Stock Market Activity - The stock price of Kanghui Co., Ltd. rose by 2.04% on November 11, reaching 23.56 yuan per share, with a trading volume of 23.57 million yuan and a turnover rate of 1.01% [1]. - The stock has appeared on the "Dragon and Tiger List" five times this year, with the most recent instance on June 16, where it recorded a net purchase of 7.7 million yuan [2]. Shareholder Information - As of September 30, the number of shareholders for Kanghui Co., Ltd. was 9,458, a decrease of 21.15% from the previous period, while the average circulating shares per person increased by 26.82% to 10,560 shares [2]. Business Overview - Kanghui Co., Ltd., established on December 24, 2009, and listed on April 21, 2017, is primarily engaged in the research, development, production, and sales of traditional Chinese medicine, with its main business revenue composition being 60.68% from pharmaceutical manufacturing and 36.79% from pharmaceutical distribution [2]. - The company operates within the pharmaceutical and biotechnology sector, specifically in the traditional Chinese medicine sub-sector [2].

Core Viewpoint - Sains has experienced a significant stock price increase of 93.93% year-to-date, but recent trading shows a decline in the short term, with a 3.92% drop over the last five trading days and a 15.49% drop over the last twenty days [1][2]. Company Overview - Sains Environmental Co., Ltd. is located in Changsha, Hunan Province, and was established on July 9, 2009. The company was listed on November 25, 2022. Its main business focuses on heavy metal pollution prevention, offering comprehensive solutions, chemical products, and operational services [1]. - The revenue composition of Sains includes: 47.50% from operational services, 39.25% from product sales, 12.42% from comprehensive solutions for heavy metal pollution prevention, and 0.68% from other sources [1]. Financial Performance - For the period from January to September 2025, Sains achieved a revenue of 677 million yuan, representing a year-on-year growth of 15.81%. However, the net profit attributable to shareholders decreased by 48.32% to 74.04 million yuan [2]. - Since its A-share listing, Sains has distributed a total of 156 million yuan in dividends [3]. Market Activity - As of November 11, Sains' stock price was 51.41 yuan per share, with a market capitalization of 4.901 billion yuan. The stock has seen a net outflow of 1.61 million yuan in principal funds, with large orders accounting for 8.55% of purchases and 21.33% of sales [1]. - The number of shareholders as of September 30 was 2,382, a decrease of 13.91% from the previous period, while the average circulating shares per person increased by 16.16% to 26,803 shares [2].